Increased inflammasome protein expression and Gal-3 have been associated with common comorbidities of NASH, such as hypertension, obesity, and type 2 diabetes, making it difficult to correlate these potential biomarkers with NASH exclusively [1,20,46]. The gene discussed is LGALS3; the disease is obesity disorder.